As a leader in sleep medicine, Jazz’s nearly 20-year leadership has been built around tackling rare sleep conditions, all while centering on and giving a voice to the patient and caregiver experiences, such as those living with idiopathic hypersomnia. Read more about our plans to expand and spotlight the I Have IH awareness campaign at SLEEP 2023. 

As we gear up for ASCO 2023, our team at Jazz is energized by the opportunity to share our research and learn about the latest advancements in cancer care, including difficult-to-treat cancers like small cell lung cancer (SCLC). It’s also an opportunity to highlight the importance of incorporating patients’ perspectives into our R&D process and supporting them and their families beyond treatment. 

Jazz is committed to developing critical medicines for people living with serious neurological conditions including epilepsy. At this year’s 2022 American Epilepsy Society (AES) annual meeting, we will present data from six abstracts showcasing Jazz’s commitment to providing medicines for people living with rare forms of epilepsy with few treatment options.

At Jazz, our purpose is to innovate to transform the lives of patients and their families. In the coming days, we are showcasing our ongoing commitment to the sleep community with our presence at SLEEP 2022, the 36th annual meeting of the Associated Professional Sleep Societies.

At Jazz, we push ourselves and other stakeholders to think holistically about patients’ health to minimize the risk of patient co-morbidities and address significant unmet needs. To learn more about the often-overlooked co-morbidities associated with narcolepsy and the progress Jazz has made to address them, Jazz's Dr. Todd Kirby spoke with sleep specialist Dr. Richard K. Bogan. 

At Jazz Pharmaceuticals, we’re committed to developing life-changing medicines for people affected by serious diseases for which current therapies are lacking. This begins with talking to those living with disease and reflecting their needs in our R&D priorities and throughout all stages of our drug development process as we pursue novel, meaningful medicines that advance patient care.